| P2093 | author name string | Brian I Carr | |
| | Robert A Branch | |
| | Venkateswarlu Kondragunta | |
| | Shama C Buch | |
| P2860 | cites work | Yttrium-90 microspheres: radiation therapy for unresectable liver cancer | Q28204605 |
| | Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival | Q29616865 |
| | Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial | Q29617955 |
| | Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma | Q29617957 |
| | Yttrium-90 Microspheres: Radiation Therapy for Unresectable Liver Cancer | Q29998867 |
| | Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients | Q30892049 |
| | Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. | Q34581507 |
| | Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis | Q34585175 |
| | Updated treatment approach to hepatocellular carcinoma. | Q36097844 |
| | Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations. | Q36573194 |
| | Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. | Q37023538 |
| | Systemic therapy for hepatocellular carcinoma: cytotoxic chemotherapy, targeted therapy and immunotherapy. | Q37072534 |
| | Preventive effect of regional radiotherapy with phosphorus-32 glass microspheres in hepatocellular carcinoma recurrence after hepatectomy | Q37189567 |
| | Gender-based outcomes differences in unresectable hepatocellular carcinoma | Q37278203 |
| | Long-term clinical outcome of phase IIb clinical trial of percutaneous injection with holmium-166/chitosan complex (Milican) for the treatment of small hepatocellular carcinoma | Q38511411 |
| | Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a case cohort study | Q44819694 |
| | New medical options for liver tumours. | Q46990863 |
| | Hepatic arterial injection chemotherapy with cisplatin suspended in an oily lymphographic agent for hepatocellular carcinoma | Q50155185 |
| | Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. | Q51593250 |
| | Intra-arterial rhenium-188 lipiodol in the treatment of inoperable hepatocellular carcinoma: results of an IAEA-sponsored multination study. | Q53231139 |
| | Causes of death in patients with unresectable hepatocellular carcinoma. | Q53487540 |
| | Evaluation of responses to chemoembolization in patients with unresectable hepatocellular carcinoma. | Q53659751 |
| | A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer | Q67483147 |
| | Mass screening for hepatocellular carcinoma: Experience in Hokkaido, Japan | Q71654408 |
| | Hepatic artery chemoembolization for advanced stage HCC: experience of 650 patients | Q77904832 |
| | Chemo-embolization for unresectable hepatocellular carcinoma with different sizes of embolization particles | Q80114603 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | yttrium | Q941 |
| | hepatocellular carcinoma | Q1148337 |
| | microsphere | Q1759020 |
| P304 | page(s) | 1305-1314 | |
| P577 | publication date | 2010-03-01 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study | |
| P478 | volume | 116 | |